ChemMedChem 2018-04-14

Design of Modular G‐quadruplex Ligands

Ana Rita Duarte; Enrico Cadoni; Ana S. Ressurreição; Rui Moreira; Alexandra Paulo

Index: 10.1002/cmdc.201700747

Full Text: HTML

Abstract

Guanine‐rich nucleic acid sequences able to form four‐stranded structures (G‐quadruplexes, G4) play key cellular regulatory roles and are considered as promising drug targets for anticancer therapy. On the basis of the organization of their structural elements, G4 ligands can be divided into three major families: one, fused heteroaromatic polycyclic systems; two, macrocycles; three, modular aromatic compounds. The design of modular G4 ligands emerged as the answer to achieve not only more drug‐like compounds but also more selective ligands by targeting the diversity of the G4 loops and grooves. The rationale behind the design of a very comprehensive set of ligands, with particular focus on the structural features required for binding to G4, is discussed and combined with the corresponding biochemical/biological data to highlight key structure–G4 interaction relationships. Analysis of the data suggests that the shape of the ligand is the major factor behind the G4 stabilizing effect of the ligands. The information here critically reviewed will certainly contribute to the development of new and better G4 ligands with application either as therapeutics or probes.

Latest Articles:

Identifying Small‐Molecule Binding Sites for Epigenetic Proteins at Domain–Domain Interfaces

2018-04-17

[10.1002/cmdc.201800030]

Fluorinated GluN2B Receptor Antagonists with a 3‐Benzazepine Scaffold Designed for PET Studies

2018-04-17

[10.1002/cmdc.201700819]

Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone‐Based Cannabinoid Receptor Type 2 Ligands

2018-04-16

[10.1002/cmdc.201800152]

Discovery of Benzimidazole–Quinolone Hybrids as New Cleaving Agents toward Drug‐Resistant Pseudomonas aeruginosa DNA

2018-04-16

[10.1002/cmdc.201700739]

Transthyretin Mimetics as Anti‐β‐Amyloid Agents: A Comparison of Peptide and Protein Approaches

2018-04-16

[10.1002/cmdc.201800031]

More Articles...